跳至主要内容
临床试验/NL-OMON42109
NL-OMON42109已完成不适用

First-in-human phase I safety, pharmacokinetic, and pharmacodynamic study of G1T28-1 in healthy male and female subjects. - G1T28-1 SAD and PD study.

G1 Therapeutics0 个研究点目标入组 58 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male or female
  • age 18 - 60 jaar, inclusive
  • BMI 18 - 32 kilogram/meter2
  • non smokers

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 3 months from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.

研究者

相似试验